10.12.2020 – 13:56
Stada Arzneimittel
STADA signs agreement to commercialize Rupafin® (rupatadine) in the MENA region - STADA secures license to market Rupafin® (rupatadine), a potent, EMA-approved second-generation antihistamine, in 10 Middle East-North Africa countries. - Mohamad Abdallah, Managing Director of STADA MENA, commented: ...
One documentmore